The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction

NCT03680404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Cardiovascular Risk Factor
Vasoconstriction

Interventions

DRUG: Control (Phenylephrine)
DRUG: Phenylephrine + Apocynin
DRUG: Phenylephrine + Allopurinol
DRUG: Phenylephrine + Tempol

Sponsor

The University of Texas at Arlington